Patent · US Expired

Immunogenic protein or peptide complex, method or producing said complex and the use thereof as an immune stimulant and as a vaccine

US4578269A · kind A · utility

56Cited by
10References
8Claims
0Family size

Inventor

Key dates

Filing dateOct 18, 1983
Grant dateMar 25, 1986
Priority date
Expiry dateOct 18, 2003

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/806
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to an immunogenic complex containing antigenic membrane proteins or peptides from viruses mycoplasmas, bacteria, parasites or animal cells or prepared synthetically or with hybride DNA technique and glycoside. The invention also relates to a process for producing the complex, whereby microorganisms, animal cells, proteins and peptides are mixed with solubilizing agents in buffered, possibly saline, solution, whereby complexes are formed between charged monomeric antigenic proteins and detergent or peptides and solubilizing agents, whereafter the charged monomeric antigenic proteins or peptides are separated from solubilizing agents in the presence of, or are separated from solubilizing agent and directly transferred to, a glycoside solution which contains one or more glycosides with hydrophobic and hydrophilic regions in a concentration of at least the critical micellular concentration, whereby a protein complex is formed, which is isolated and purified. The invention also relates to the use of the immunogenic complex as an immunity-stimulating agent, especially as a vaccine, and compositions containing the complex.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.